Medicare Part D coverage · ganciclovir · RxCUI 864650
ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan]
Per the CMS 2026 Part D formulary file, ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] is covered by 4,551 Medicare Part D plans (90.1% of enrollable products), averaging Tier 3.4, with prior authorization required on 0% of covering formularies.
- 90.1%
- Plan coverage
- 4,551
- Plans covering
- T3.4
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan]
Per the CMS 2026 Part D formulary file, ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] (RxNorm concept RXCUI 864650, generic name ganciclovir) appears on 240 distinct formulary files spanning 4,551 Medicare Part D plan offerings - 90.1% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.4.
Real-world access to ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 1.3% require step therapy. 5.8% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 11,222 Part D beneficiaries filled ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] in 2023, with total plan-and-beneficiary spending of $9,445,994 and an average per-beneficiary annual cost of $841.74. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] today.
Coverage Details
- Formularies covering
- 240
- Plans covering
- 4,551
- Coverage rate
- 90.1%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 1.3% of formularies
- Quantity limits
- 5.8% of formularies
2023 Medicare Spending
- Beneficiaries
- 11,222
- Total spending
- $9,445,994
- Avg per beneficiary
- $841.74
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | No | $0 | VA |
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | No | $0 | FL |
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $0 | NJ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | No | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | No | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | No | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | No | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | No | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | No | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | No | $0 | NY |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | No | $0 | GA |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | No | $0 | MA |
Show the next 30 plans
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | No | $0 | MI |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | No | $0 | MA |
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | No | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | No | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | No | $0 | MD |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | No | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $0 | MO |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | No | $0 | AR |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | No | $0 | PR |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | No | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | No | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | No | $0 | DE |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] covered by Medicare Part D?
Yes, ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] is covered by 4,551 Medicare Part D plans (90.1% of all Part D formularies).
What tier is ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] on Medicare Part D plans?
ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] averages Tier 3.4 across Part D plans, ranging from Tier 1 to Tier 4.
Does ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] require prior authorization?
0% of Part D formularies require prior authorization for ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan]. Step therapy: 1.3%. Quantity limits: 5.8%.
How much does Medicare spend on ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan]?
In 2023, total Medicare Part D spending on ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] was $9,445,994, covering 11,222 beneficiaries. The average spend per beneficiary was $841.74.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- pentosan polysulfate 100 MG Oral Capsule [Elmiron] T3.4
- erythromycin lactobionate 500 MG Injection [Erythrocin] T3.4
- mafenide 85 MG/ML Topical Cream [Sulfamylon] T3.4
- 1 ML darbepoetin alfa 0.06 MG/ML Injection [Aranesp] T3.4
- 1 ML denosumab-dssb 60 MG/ML Prefilled Syringe [Ospomyv] T3.4
- {5 (dienogest 2 MG / estradiol valerate 2 MG Oral Tablet) / 17 (dienogest 3 MG / estradiol valerate 2 MG Oral Tablet) / 2 (estradiol valerate 1 MG Oral Tablet) / 2 (estradiol valerate 3 MG Oral Tablet) / 2 (inert ingredients 1 MG Oral Tablet) } Pack [Natazia 28 Day] T3.4